Most a short while ago, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in related parts as classical opioid receptors, it binds to some big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger and won't activate a 2nd